Crispr Wins Key Approval to Fight Cancer in Human Trials

The first use of a gene-editing tool to rewrite our immune system DNA is one step away.

How Genetic Engineering Tool Crispr Could Change Humanity

An experimental cancer treatment that alters the DNA of patients has won a key approval to proceed with its first human tests using the controversial gene-altering tool known as Crispr

To continue reading this article you must be a Bloomberg Professional Service Subscriber.